Feng Jin - Concepedia

Author

Feng Jin

Guizhou Cancer Hospital ORCID

Also Known As

D L Zhao, F Jin, F. Jin, Feng Jin, Feng Jin,, Feng-Wei Jin, J Feng, Jin Feng, Xiao-Xia Gou, Xin-Qiong Huang

134

Publications

9.3K

Citations

H-Index

Concepts

All Affiliations

Guizhou Cancer Hospital Sun Yat-sen University Sun Yat-sen University Cancer Center Guiyang Medical University Affiliated Hospital of Guizhou Medical University

About

Feng Jin is an author at Guizhou Cancer Hospital specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	24	7K
2	Health Sciences	9	9	223
3	Engineering	1	1	41
4	Natural Sciences	1	1	32
5	Public Health	1	1	5.9K

Feng Jin

Publications

Citations

H-Index

Page 1

	Year	Citations
Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries Claudia Allemani, Tomohiro Matsuda, V Di Carlo, The Lancet EpidemiologyCancer EpidemiologyMedicineGlobal HealthCancer Management	2018	5.9K
Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma Yuan Zhang, Lei Chen, Guoqing Hu, New England Journal of Medicine	2019	889
Toripalimab or placebo plus chemotherapy as first-line treatment in advanced nasopharyngeal carcinoma: a multicenter randomized phase 3 trial Hai-Qiang Mai, Qiu-Yan Chen, Dongping Chen, Nature Medicine OncologyMetronomic TherapyNasopharyngeal CancerFirst-line TreatmentCancer Treatment	2021	387
The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma Ling‐Long Tang, Yu‐Pei Chen, Chuanben Chen, Cancer Communications	2021	374
Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial Yu‐Pei Chen, Xu Liu, Qin Zhou, The Lancet OncologyAdvanced Nasopharyngeal CarcinomaMetronomic TherapyNasopharyngeal CancerPathology	2021	217
Toripalimab Plus Chemotherapy for Recurrent or Metastatic Nasopharyngeal Carcinoma Hai‐Qiang Mai, Qiuyan Chen, Dongping Chen, JAMA	2023	196
Final Overall Survival Analysis of Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma: A Multicenter, Randomized Phase III Trial Yuan Zhang, Lei Chen, Guoqing Hu, Journal of Clinical Oncology	2022	129
Subunit 6 of the COP9 signalosome promotes tumorigenesis in mice through stabilization of MDM2 and is upregulated in human cancers Ruiying Zhao, Sai‐Ching J. Yeung, Jian Chen, Journal of Clinical Investigation	2011	106
A randomized phase II trial of induction chemotherapy followed by cisplatin chronotherapy versus constant rate delivery combined with radiotherapy P.X Zhang, Feng Jin, Zi-Hang Li, Chronobiology International Adaptive RadiotherapyFlat Intermittent InfusionControl GroupRadiation MedicineRadiation Therapy	2017	53
Effect of <i>Kangfuxin</i> Solution on Chemo/Radiotherapy‐Induced Mucositis in Nasopharyngeal Carcinoma Patients: A Multicenter, Prospective Randomized Phase III Clinical Study Yangkun Luo, Mei Feng, Zixuan Fan, Evidence-based Complementary and Alternative Medicine Control GroupAllergyGastrointestinal OncologyMedicineGastrointestinal Pharmacology	2016	44

Page 1